Global rubella vaccine coverage reaches 87% of countries, but elimination achieved in only 42%

A global surveillance report tracked progress toward rubella and congenital rubella syndrome control and elimination across 194 countries from 2000 to 2018. The study type, phase, and primary outcome were not reported. The intervention examined was rubella-containing vaccine implementation, with no specific comparator detailed.

Main results showed that 168 of 194 countries (87%) protected infants with rubella-containing vaccine by 2018. However, only 81 of 194 countries (42%) had achieved elimination of rubella transmission. The report did not provide confidence intervals, p-values, or direction of effects for these findings.

Safety and tolerability data were not reported. Key limitations include the absence of reported study design, primary outcome measures, and statistical analyses. Funding sources and conflicts of interest were also not disclosed.

For clinical practice, these data provide a broad snapshot of global rubella vaccine implementation but lack the methodological detail needed for causal inference or precise program evaluation. The findings suggest substantial progress in vaccine introduction but highlight that more than half of countries worldwide have not yet eliminated rubella transmission.